DIFFUSION PHARMACEUTICALS INC.
Profile
Company Names
DIFFUSION PHARMACEUTICALS INC.
RESTORGENEX CORP
STRATUS MEDIA GROUP, INC
Addresses
1317 CARLTON AVENUE, SUITE 200, CHARLOTTESVILLE, VA 22902
2020 AVON COURT, SUITE 4, CHARLOTTESVILLE, VA 22902
1800 CENTURY PARK EAST, 6TH FLOOR, LOS ANGELES, CA 90067
3 E. DE LA GUERRA STREET, SANTA BARBARA, CA 93101
Phone Numbers
(434) 220-0718
310.526.8700
805-884-9977
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, OTHER
Year Incorporated:
> 5 years ago
State Incorporated:
NEVADA
Total Amount Raised:
$139,958,020.00
Number of Funding Rounds:
9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2020-05-20
$750,001.00
$750,001.00
$0.00
8
2020-05-08
$625,000.00
$625,000.00
$0.00
7
2019-12-13
$783,348.00
$783,348.00
$0.00
6
2019-05-23
$164,132.00
$164,132.00
$0.00
5
2017-03-14
$15,830,661.00
$25,000,000.00
$9,169,339.00
Equity
4
2016-01-08
$85,736,378.00
INDEFINITE
INDEFINITE
Equity
3
2014-04-29
$24,778,500.00
$50,000,000.00
$25,221,500.00
Equity
2
2011-05-25
$8,700,000.00
$10,000,000.00
$1,300,000.00
Equity
1
2011-04-15
$2,590,000.00
$2,615,000.00
$25,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
SOL
BARER
DIRECTOR
ISAAC
BLECH
DIRECTOR
SOCIALWISE, INC. (FORMERLY KNOWN AS IDEAEDGE, INC)
| CONTRAFECT CORP
| BILLMYPARENTS, INC.
| CERECOR INC.
| MEDGENICS, INC.
| PREMIER ALLIANCE GROUP, INC.
| EDGE THERAPEUTICS, INC.
| SPENDSMART PAYMENTS CO
| CENTREXION CORP
| RESTORGENEX CORP
| ROOT9B TECHNOLOGIES INC.
| WAVEGUIDE CORP
| X4 PHARMACEUTICALS, INC.
| ROOT9B TECHNOLOGIES, INC.
| INSPIREMD, INC.
| CENTREXION THERAPEUTICS CORP
| SAPIENCE THERAPEUTICS, INC.
| ARIDIS PHARMACEUTICALS, INC.
| X-VAX TECHNOLOGY, INC.
| REGENOVATION, INC.
| DIFFUSION PHARMACEUTICALS INC.
| NACUITY PHARMACEUTICALS, INC.
| ELUCIDA ONCOLOGY, INC.
| MARINA BIOTECH, INC.
| ALVEO TECHNOLOGIES INC.
| VEDANTRA PHARMACEUTICALS, INC.
PAUL
FELLER
EXECUTIVE OFFICER, DIRECTOR
JOHN
L.
GAINER
EXECUTIVE OFFICER, DIRECTOR
MARK
T.
GILES
DIRECTOR
DAVID
G.
KALERGIS
EXECUTIVE OFFICER, DIRECTOR
WILLIAM
KELLY
EXECUTIVE OFFICER
DAVID
SHERRIS
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-03-14
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
$1 - $1,000,000
Equity
2016-01-08
D
PHARMACEUTICALS
SERVICES-AMUSEMENT + RECREATION SERVICES [7900]
$1 - $1,000,000
Equity
2014-04-29
D
OTHER
SERVICES-MISCELLANEOUS REPAIR SERVICES [7600]
$1 - $1,000,000
Equity
2011-05-25
D
OTHER
SERVICES-MISCELLANEOUS REPAIR SERVICES [7600]
$1 - $1,000,000
Equity
2011-04-15
